Combining Serum GFAP and NfL Predicts Progression Independent of Relapse Activity in B-Cell–Depleted MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis
Ann. Neurol 2024 Oct 16;[EPub Ahead of Print], P Benkert, A Maleska Maceski, S Schaedelin, J Oechtering, A Zadic, JF Vilchez Gomez, L Melie-Garcia, A Cagol, R Galbusera, S Subramaniam, J Lorscheider, E Galli, J Mueller, B Fischer-Barnicol, L Achtnichts, O Findling, PH Lalive, C Bridel, M Uginet, S Müller, C Pot, A Mathias, R Du Pasquier, A Salmen, R Hoepner, A Chan, G Disanto, C Zecca, M D'Souza, LG Hemkens, Ö Yaldizli, T Derfuss, P Roth, C Gobbi, D Brassat, B Tackenberg, R Pedotti, C Raposo, J Oksenberg, H Wiendl, K Berger, M Hermesdorf, F Piehl, D Conen, A Buser, L Kappos, M Khalil, C Granziera, A Abdelhak, D Leppert, EAJ Willemse, J KuhleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.